Business


Akebia Therapeutics Inc (AKBA) Receives Buy Rating from Needham & Company LLC

H.C. Wainwright analyst Ed Arce commented, "We view this as a substantial, landmark win for Akebia given that Fresenius now treats over 185,000 dialysis patients, representing almost 40% of the estimated $3.5B U.S. Akebia Therapeutics presently has a consensus rating of "Buy" and a consensus target price of $17.57. Equities research analysts anticipate that Akebia Therapeutics will post ($2.98) EPS for the current fiscal year.


FTC not ready to move on Walgreens-Rite Aid deal

FTC not ready to move on Walgreens-Rite Aid deal

Walgreens was largely unchanged at $84.52, a drop of 0.08% or 7 cents. About 625,260 shares traded. Rite Aid Corporation (NYSE:RAD)'s stock has performed at -50.12% year to date. Time Warner Inc (NYSE:TWX) was raised too. Now it is offering a dividend yield of 2.40% and a 5 year dividend growth rate of 15.11%. Therefore 60% are positive.



John Terry says he could retire at the end of this season

Outgoing John Terry as well as Michy Batshuayi, Cesc Fabregas and Cesar Azpilicueta all hit the scoreboard, pipping Watford in the 88th minute of the game. "You start to plan ten days before". Download the Nigeria Today app from Play store. Genuinely, I haven't made any decisions as of yet and I'm just evaluating all my options at the moment.



Monday morning blues as 'WannaCry' hits at workweek's start

Then came word that networks around the world were under attack Friday. It quickly put out a "highly unusual" security patch for the out-of-support Windows XP, Windows 8, and Windows Server 2003 operating systems over the weekend to protect its customers.



Price Target Review on RLJ Lodging Trust (NYSE:RLJ)

The net percent change held by Institutional Investors has seen a change of -1.23% in last three month period. The company had a trading volume of 2,571,951 shares. Insiders own 1.50% of the company shares. Murphy Oil Corporation (NYSE:MUR), stock is trading $34.56 above the 52-week high and has displayed a high EPS growth of -20.80% in last 5 years.